Skip to content

8-KAccepted Oct 2, 7:38 PM ET

Co-Diagnostics, Inc.: Annual meeting adjourned to Oct 14, 2026

CODXCo-Diagnostics, Inc.

Accepted (ET)

7:38 PM

Oct 2, 2026

Filed

Oct 5, 2026

Documents

11

Size

199.9 KB

Summary

Co-Diagnostics, Inc.: Annual meeting adjourned to Oct 14, 2026

Updated

What happened

  • The filing reports that Co-Diagnostics, Inc. held its annual meeting on Sep 3, 2026 but did not achieve a quorum and was unable to transact business.
  • The meeting was adjourned to Sep 24, 2026 and then to Sep 30, 2026, and again adjourned to Oct 14, 2026 at 9:30 a.m. Mountain Time to be held at the company’s offices at 2401 S. Foothill Drive, Suite D, Salt Lake City, Utah 84109.

Key details

  • The company reported that it "did not achieve a quorum" at the meetings on Sep 3, 2026 and Sep 24, 2026 and again on Sep 30, 2026.
  • The reconvened annual meeting is scheduled for Oct 14, 2026 at 9:30 a.m. Mountain Time at the company’s Salt Lake City offices.
  • The filing cites the bylaws authorizing the chairperson to adjourn a meeting "from time to time, without notice other than announcement at the meeting, until a quorum is present or represented."
  • Valid proxies submitted prior to the reconvened meeting "will continue to be valid" unless changed or revoked before votes are taken at the reconvened meeting.

Why it may matter

  • The filing reports Item 5.07 (submission of matters to a vote of security holders), which covers the reconvening and voting procedures for the annual meeting after the company did not achieve a quorum.
  • This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing